NCT01981551 2024-02-06Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive FibromatosisNational Institutes of Health Clinical Center (CC)Phase 2 Completed17 enrolled 14 charts